Effect of DT-TX 30, a combined thromboxane synthase inhibitor and thromboxane receptor antagonist, on retinal vascularity in experimental diabetes mellitus.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples